Latest Global Growth News

CurveBeam AI has inked a decade-long exclusive partnership with a major Chinese medical device joint venture, unlocking rapid market entry and a $10 million capital boost to expand its weight bearing CT and AI solutions across Greater China.

Sprintex Limited has transitioned from development to commercial execution, securing major contracts in Europe, China, and India while raising A$1.5m to fund expansion.

Associate Global Partners Limited reported a 4.6% increase in funds under management to $1.464 billion for Q3 2025, driven by robust inflows and standout returns from its WCM strategies. The company also sustained positive operating cash flows for the fourth consecutive quarter.

Orbital Corporation Ltd reports a robust Q1 2025 with increased revenues, successful prototype completion of a new 350cc heavy fuel engine, and strategic partnerships positioning it for growth in the evolving UAV market.

DUG Technology reports a robust start to FY26 with 19% revenue growth and a landmark SaaS and HPCaaS contract, marking key international milestones.

Murray Cod Australia Ltd reports a robust start to FY26 with a 45% increase in sales and a $17 million capital raise, driven by expanded production and market access including new Halal certification.

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.

Franklin Templeton Australia has launched the Franklin Global Growth Fund – Class A, an actively managed ETF listed on the ASX aiming to outperform the MSCI World ex Australia Index with a strong ESG commitment and a 0.90% management fee.

DroneShield has promoted Angus Harris to Chief Technology Officer, reinforcing its leadership as it scales to meet rising global demand in defence markets. Meanwhile, Angus Bean shifts to Chief Product Officer to sharpen the company’s product strategy.

Orthocell has raised $30 million through an institutional placement to accelerate the US commercialisation of its flagship nerve repair product Remplir and expand its regenerative medicine portfolio.

Audeara Limited has landed its maiden purchase order for hearing aid technology in China, marking a pivotal step in its global expansion with production and launch planned for the final quarter of 2025.

Fiducian Group Limited has reported a robust 23% increase in net profit after tax for the year ended June 2025, driven by strong inflows and resilient performance across its financial planning, platform administration, and investment management segments despite challenging market conditions.